EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Timing of Onset of Garadacimab for Preventing Hereditary Angioedema Attacks

Petra Staubach, Raffi Tachdjian, H Henry Li, Roman Hakl, Emel Aygören-Pürsün, Lolis Wieman, John-Philip Lawo, Timothy J Craig

Clinical & Experimental Allergy · 2024-12 · 54 (12) · 1020-1023

DOI: 10.1111/cea.14568 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Allergy, 2024-10. Verfasst von Petra Staubach und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Allergy, University Medical Center Mainz, Mainz, Germany. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSL Behring.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

- Garadacimab provided consistent HAE attack prevention in manufacturer-funded post hoc pivotal Phase 3 data analysis. - Protection from HAE attacks occurred by Week 1 after first administration.

Schlagwörter

Stichwörter der Autor:innen

attack freeearly onsetgaradacimabhereditary angioedemalong‐term prophylaxis

Autor:innen und Institutionen

  • Department of Dermatology and Allergy, University Medical Center Mainz, Mainz, Germany.
  • Division of Allergy and Clinical Immunology, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California, USA.
  • Institute for Asthma and Allergy, Chevy Chase, Maryland, USA.
  • Department of Clinical Immunology and Allergology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czech Republic.
  • Department for Children and Adolescents, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt, Germany.
  • CSL Behring, King of Prussia, Pennsylvania, USA.

Förderung

  • CSL Behring

Zitieren

APA

Staubach, P., Tachdjian, R., Li, H. H., Hakl, R., Aygören-Pürsün, E., Wieman, L., Lawo, J. P., & Craig, T. J. (2024). Timing of Onset of Garadacimab for Preventing Hereditary Angioedema Attacks. Clinical & Experimental Allergy, 54(12), 1020-1023. https://doi.org/10.1111/cea.14568

Vancouver

Staubach P, Tachdjian R, Li HH, Hakl R, Aygören-Pürsün E, Wieman L, et al. Timing of Onset of Garadacimab for Preventing Hereditary Angioedema Attacks. Clinical & Experimental Allergy. 2024;54(12):1020-1023. doi:10.1111/cea.14568

BibTeX
@article{Staubach2024,
  author = {Staubach, Petra and Tachdjian, Raffi and Li, H Henry and Hakl, Roman and Aygören-Pürsün, Emel and Wieman, Lolis and Lawo, John-Philip and Craig, Timothy J},
  title = {Timing of Onset of Garadacimab for Preventing Hereditary Angioedema Attacks},
  journal = {Clinical & Experimental Allergy},
  year = {2024},
  volume = {54},
  number = {12},
  pages = {1020--1023},
  doi = {10.1111/cea.14568}
}
Kostenlos starten →